Seminars on Drug Pricing: Part 5 Kevin Outterson, Antibiotic Delinkage
UPDATED:
Here is a link to the recording of the seminar. Please see Professor Outterson’s slideshow for more detail and explanation.
Original
Continue Reading
UPDATED:
Here is a link to the recording of the seminar. Please see Professor Outterson’s slideshow for more detail and explanation.
Original
Continue Reading
UPDATED:
Here is a link to the recording of the seminar. Please see Bhaven’s slideshow for more detail and explanation.
Original
Continue Reading
Six NGOs — including Oxfam America, Health GAP, Knowledge Ecology International (KEI), the Union for Affordable Cancer Treatment (UACT), the Young Professionals Chronic Disease Network (YP-CDN), and Public Citizen — sent a letter to President Obama today asking him to publicly express the United States’ “full and unconditional support” for the waiver of World Trade Organization (WTO) drug patent rules for Least Developed Countries (LDCs). Continue Reading
This is a copy of recommendations for an Indian National IPR Policy, written by the “IP Think Tank,” which was constituted by the Department of Industrial Policy & Promotion(DIPP), Ministry of Commerce and Industry, Government of India. A copy scanned from a hard copy is here.
The members of the IPR Think Tank were:
Leaked text can be found here.
On 9 October 2015, Wikileaks released the final text of the IP chapter in the Trans-Pacific Partnership. Jamie Love provided comments via twitter.
https://twitter.com/jamie_love
Updated: 9 October 2015
(In the order posted)
This is a video by Zack Struver about Senator Bernie Sander’s proposal to expand Veterans access to patented medical inventions. The video discusses both the proposal by Senator Sanders to give the U.S. Department of Veterans Affairs the authority to use compulsory licenses on patents on medical inventions, including drugs, and the history of “government use” provisions in current U.S. statutes, including 28 U.S.C. 1498, which Sanders proposes modifying.
IMS Health, the global information and technology services company, known for its statistics on sales of drugs, published a study in May 2015 that estimated the global market for oncology drugs now exceeds $100 billion per year.
The attached PDF file is a KEI briefing note on the evolution of certain sections of the TPP negotiating text on patents and patentable subject matter.
UPDATED:
Here is a link to the recording of the seminar. Please see Aidan’s paper and slideshow for more detail and explanation.
Original
Continue Reading